+1 862 778 5388 (for reporters only)
+1 732 673 5262 
PAF Enrollment
Novartis is committed to providing access to our medications for those most in need through the Novartis Patient Assistance Foundation, Inc. (PAF). PAF provides assistance to patients experiencing financial hardship who have no third party insurance coverage for their medicines.
Questions?
Contact the Novartis Patient Assistance Foundation, Inc. at 800.277.2254
To be eligible for Novartis PAF, patients must:
- Be a U.S. resident
- Provide proof of income within program guidelines
- Not have private or public prescription coverage
Enrollment Process
........................................................................................
- Apply via Fax/Mail
To get started, select a product from the list below and follow the instructions.
Please be advised that access to the medicines distributed through the Novartis Patient Assistance Foundation, Inc. is free of charge to all eligible patients. A nominal co-pay for Novartis products using a pharmacy card will apply. Novartis is not affiliated with any individual or organization that may charge patients a fee(s) to assist them in completing applications for our program. These individuals or organizations are acting independently the Novartis Patient Assistance Foundation, Inc and its affiliates and do not have Novartis' consent.
....................................................................................................................
Please be advised that access to the medicines distributed through the Novartis Patient Assistance Foundation, Inc. is free of charge to all eligible patients. A nominal co-pay for Novartis products using a pharmacy card will apply. Novartis is not affiliated with any individual or organization that may charge patients a fee(s) to assist them in completing applications for our program. These individuals or organizations are acting independently the Novartis Patient Assistance Foundation, Inc and its affiliates and do not have Novartis' consent.
Enrollment Process
Novartis Patient Assistance Foundation
PO Box 66531
St. Louis, MO 63166-6531
1-800-277-2254
Download the PAF Enrollment Application (English)
Download the PAF Enrollment Application (Espaol-Spanish)
Enrolling in the Novartis Patient Assistance Foundation is quick and easy.
- You or your physician can call Novartis at 1-800-277-2254, selecting the appropriate phone prompts. You can request a faxed application by choosing the correct prompt and entering a fax number. Applications can be downloaded in a PDF format by following the links on the right hand side of this page.
- You will need to complete the upper portion of the application, and include your signature, the date and a copy of your most recent Federal Tax Return.
- Your physician should complete the lower portion of the enrollment application and attach a prescription for a three-month supply. Focalin® XR and Ritalin® LA are supplied through a pharmacy card.
- Qualifying individuals are eligible for up to one year of assistance, or until a prescription drug benefit becomes available to you. Upon approval, a 30 or 90-day supply of medication will be shipped directly to your physician. For Focalin® XR and Ritalin® LA, a pharmacy card will be issued.
- To obtain an additional 30 or 90-day supply of medication, a refill request form (included with each shipment) must be submitted along with a new prescription, or your physician can call 1-800-277-2254 to request a refill. For Focalin® XR and Ritalin® LA refills, you must obtain a prescription from your physician and take the prescription and your pharmacy card to a retail pharmacy for a refill.
NOTE: Patients who need assistance for multiple treatment areas must complete the enrollment process for each applicable product.
Enrollment Process
Novartis Oncology Patient Assistance Program
PO Box 66531
St. Louis, MO 63166-6531
1-800-277-2254
Download the PAF Enrollment Application
To get started, you or your physician can call EPASSTM Prescription and Reimbursement Hotline at 1-888-903-7277
NOTE: Patients who need assistance for multiple treatment areas must complete the enrollment process for each applicable product.
Oncology PAP Program Enrollment Process
Novartis Oncology Patient Assistance Program
PO Box 66559
St. Louis, MO 63166-6559
1-800-277-2254
Enrolling in the Novartis Oncology Patient Assistance is quick and easy.
- To provide you with the best possible customer service, we recommend that you or your physician call our hotline.You will be asked a few qualifying questions to determine your eligibility for the program,and if found eligible you will be provided with a temporary supply of medication while you fill out the patient assistance program application.
- To get started,please call 1-800-277-2254 and select the appropriate phone prompts.
** Please note for patients prescribed Exjade®, you or your physician should call EPASS Prescription and Reimbursement Hotline at 1-888-903-7277.
- If you [appear to] qualify for the patient assistance program based on this initial phone screening you will recieve, a temporary supply of medication and an application will be mailed directly to the patients home. Once received, you must complete the first four sections of the application, and include your signature, the date, a copy of your most recent Federal Tax Return, and a copy of your insurance card/prescription card, if applicable. Your physician must complete and sign the lower portion of the enrollment application.
- Alternatively you download a copy of the application from this site and fill it out and send to us directly at the above address, or fax it to us at 1-866-277-9335.Once received we will assess your full eligibility for the patient assistance program.
- Qualifyied individuals are eligible for up to one year of assistance, or until a prescription drug benefit becomes available to you. Upon approval, up to a year supply of medication will be shipped directly to you or your physician.
Download the Oncology PAP Enrollment Application (English)
Download the Oncology PAP Enrollment Application (Español-Spanish)
Oncology PAP Program Enrollment Process
Novartis Oncology Patient Assistance Program
PO Box 66559
St. Louis, MO 63166-6559
1-800-277-2254
Enrolling in the Novartis Oncology Patient Assistance is quick and easy.
- To provide you with the best possible customer service, we recommend that you or your physician call our hotline.You will be asked a few qualifying questions to determine your eligibility for the program,and if found eligible you will be provided with a temporary supply of medication while you fill out the patient assistance program application.
- To get started,please call 1-800-277-2254 and select the appropriate phone prompts.
** Please note for patients prescribed Exjade®, you or your physician should call EPASS Prescription and Reimbursement Hotline at 1-888-903-7277.
- If you [appear to] qualify for the patient assistance program based on this initial phone screening you will recieve, a temporary supply of medication and an application will be mailed directly to the patients home. Once received, you must complete the first four sections of the application, and include your signature, the date, a copy of your most recent Federal Tax Return, and a copy of your insurance card/prescription card, if applicable. Your physician must complete and sign the lower portion of the enrollment application.
- Alternatively you download a copy of the application from this site and fill it out and send to us directly at the above address, or fax it to us at 1-866-277-9335.Once received we will assess your full eligibility for the patient assistance program.
- Qualifyied individuals are eligible for up to one year of assistance, or until a prescription drug benefit becomes available to you. Upon approval, up to a year supply of medication will be shipped directly to you or your physician.
Download the Oncology PAP Enrollment Application (English)
Download the Oncology PAP Enrollment Application (Español-Spanish)
Enrollment Process
For patients who cannot afford the cost of Reclast® and lack insurance, the Patient/Physician can call 1-800-833-0166.
Enrollment Process
For patients who cannot afford the cost of Ilaris® treatment and lack insurance, the Patient/Physician may call the Ilaris Patient Support Program at 1-866-972-8315.
Enrollment Process
For patients who cannot afford the cost of Extavia® treatment and lack insurance, the Patient/Physician may call the Extavia® Go Program at 1-866-925-2333.
Enrollment Process
For patients who cannot afford the cost of Gilenya™ treatment and lack insurance, the Patient/Physician may call the Gilenya™ Go Program at 1-877-408-4974.
Enrollment Process
TOBI Patient Assistance Program
PO Box 66978
St. Louis, MO 63166-6978
1-877-862-4423
Enrolling in the TOBI® Patient Assistance is quick and easy.
To get started, you or your physician can call the TOBI® Patient Assistance Program at 1-877-862-4423.
NOTE: Patients who need assistance for multiple treatment areas must complete the enrollment process for each applicable product.
Enrollment Process
For patients who cannot afford the cost of Visudyne® and lack insurance, the Physician can call 1-877-736-2778.
Enrollment Process
Novartis Patient Assistance Program for Specialty Medicines
PO Box 66531
St. Louis, MO 63166-6531
1-800-277-2254
Fax: 866-470-1750 (if the application is faxed it must be sent from the physician's office)
Download the Novartis PAP Application for Specialty Medicines
Enrolling in the Novartis Patient Assistance Program for Specialty Medicines is quick and easy.
- You can participate in a brief phone screening to help us understand your needs. You or your physician can call Novartis at 1-800-277-2254, selecting the appropriate phone prompts, or you can download the above application.
- You will need to complete all patient and physician sections of the attached application. You will need to attach an original prescription for the requested medication (refills may be included).
- Please attach a copy of your household's most recent year federal tax returns or financial documents.
- Please include your annual out-of-pocket medical expenses on the application.
- Mail or fax the application, prescription, and financial documentation to the address above.
NOTE: Patients who need treatments from multiple treatment areas must complete enrollment processes in as many areas as applicable.
Clozaril®(clozapine)
Type: Clozaril®
Supply: 30-days
Distribution:Pharmacy Card
........................................................................................
Enrollment Process
Clozaril® Patient Assistance Program
PO Box 66531
St. Louis, MO 63166-6531
1-800-277-2254
Enrolling in the Clozaril® Patient Assistance Program is quick and easy.
- Novartis requires all patients to participate in a brief phone screening to help us understand your needs. You or your physician can call Novartis at 1-800-277-2254, selecting the appropriate phone prompts.
- Following the phone screening, an application will be sent to you or your physician as requested.
- You will need to complete the upper portion of the application and include your signature, the date and a copy of your most recent Federal Tax Return. Your physician will need to complete and sign the lower portion of the enrollment application.
- Clozaril® (clozapine) is dispensed through a retail pharmacy card that is sent directly to the physician.
- Upon written notification of approval, qualified patients will pick up the approved pharmacy card from the physician, along with a valid prescription, and take both items to the pharmacy to receive the medication.
NOTE: Patients who need treatments from multiple treatment areas must complete enrollment processes in as many areas as applicable.
Afinitor®(everolimus) tablets
Type: Oncology Products Sponsored
........................................................................................
Diovan®(valsartan hydrochloride)
Type: Mass Market Products Sponsored
........................................................................................
Exelon®(rivastigmine tartrate)
Type: Mass Market Products Sponsored
........................................................................................
Tekamlo™(aliskiren and amlodipine)
Type: Mass Market Products Sponsored
........................................................................................
Exelon® Patch(rivastigimine transdermal system)
Type: Mass Market Products Sponsored
........................................................................................
Exforge® (amlodipine and valsartan)
Type: Mass Market Products Sponsored
........................................................................................
Exforge HCT® (amlodippine, valsartan, and hydrochlorothiozide)
Type: Mass Market Products Sponsored
........................................................................................
Exjade®(deferasirox)
Type: Oncology Products Sponsored
........................................................................................
Famvir® (famciclovir)
Type: Mass Market Products Sponsored
........................................................................................
Focalin® XR (dexmethylphenidate hydrochloride extended release capsules)
Type: Mass Market Products Sponsored
........................................................................................
Type: Oncology Products Sponsored
........................................................................................
Lamisil® Oral Granules (terbinafine hydrochloride)
Type: Mass Market Products Sponsored
........................................................................................
Miacalcin® Injection & Nasal Spray (calcitonin-salmon)
Type: Mass Market Products Sponsored
........................................................................................
Hecoria™(tacrolimus capsules, USP)
Type: Specialty Medicines PAP Program Enrollment Process
........................................................................................
Myfortic® (mycophenolic acid)
Type: Specialty Medicines PAP Program Enrollment Process
........................................................................................
Neoral®(cyclosporine soft gelatin capsule, USP)
Type: Specialty Medicines PAP Program Enrollment Process
........................................................................................
Amturnide™ tablets
Type: Mass Market Products Sponsored
........................................................................................
Focalin® XR(dexmethylphenidate)
Type: Focalin® XR
Distribution: Pharmacy Card
........................................................................................
Arcapta™ Neohaler™(indacaterol inhalation powder)
Type: Mass Market Products Sponsored
........................................................................................
Reclast® (zolendronic acid)
Type: Reclast
Supply: 1 Bottle
Distribution: Shipped to physician
........................................................................................
Sandimmune® (cyclosporine capsules, USP; cyclosporine oral solution, USP; cyclosporine injection, USP)
Type: Specialty Medicines PAP Program Enrollment Process
........................................................................................
Sandostatin LAR® Depot
Type: Oncology Products Sponsored
........................................................................................
Signifor® Injection(Pasireotide)
Type: Oncology Products Sponsored
........................................................................................
Tasigna® (nilotinib)
Type: Oncology Products Sponsored by PAF
........................................................................................
Tegretol®(carbamazepine)
Type: Mass Market Products Sponsored
........................................................................................
Tegretol-XR® (carbamazepine extended release)
Type: Mass Market Products Sponsored
........................................................................................
Type: Mass Market Products Sponsored
........................................................................................
Type: Mass Market Products Sponsored
........................................................................................
TOBI® (tobramycin inhalation solution USP)
Type: TOBI Patient Assistance Program
Supply: 30-days
Distribution: Shipped to patient
........................................................................................
TOBI®Podhaler™ (tobramycin inhalation)
Type: TOBI Patient Assistance Program
Supply: 30-days
Distribution: Shipped to patient
........................................................................................
Trileptal® (oxcarbazepine)
Type: Mass Market Products Sponsored
........................................................................................
Tyzeka® (telbivudine)
Type: Specialty Medicines PAP Program Enrollment Process
........................................................................................
Coartem® (artemether and lumefantrine)
Type: Specialty Medicines PAP Program Enrollment Process
........................................................................................
Fanapt® (iloperidone)
Type: Specialty Medicines PAP Program Enrollment Process
Distribution: Shipped to physician
........................................................................................
ENOXAPARIN SODIUM
Type: Specialty Medicines PAP Program Enrollment Process
........................................................................................
Visudyne® (verteporfin for injection)
Type: Visudyne
Supply: 1 vial
Distribution: Shipped to Physician
........................................................................................
Voltaren Ophthalmic® (diclofenac sodium ophthalmic solution)
Type: Mass Market Products Sponsored
........................................................................................
Zometa® (zoledronic acid for injection)
Type: Oncology Products Sponsored by PAF
........................................................................................
Afinitor® (everolimus) tablets
Type: Oncology Products Sponsored by PAF
........................................................................................
Ilaris® (canakinumab)
Type: Specialty Medicines PAP Program Enrollment Process
Distribution: Shipped to physician
........................................................................................
Extavia® (interferon beta-1b) Injection
Type: Specialty Medicines PAP Program Enrollment Process
Distribution: Shipped to Patient
........................................................................................
Gilenya™ (fingolimod) capsules
Type: Specialty Medicines PAP Program Enrollment Process
Distribution: Shipped to Patient
........................................................................................
Zortress® (everolimus)
Type: Specialty Medicines PAP Program Enrollment Process
........................................................................................
